You are here: Industry Insights > Sputnik V vaccine

News List

Sputnik V vaccine shows 92 per cent efficacy in ongoing phase III trials in Russia expresspharma
November 12, 2020
The confirmation is based on the first interim data from the double-blind, randomized, placebo-controlled Phase III clinical trials in Russia involving 40,000 volunteers.
RDIF and União Química file documents for registration of Sputnik V vaccine with regulator in Brazil worldpharmanews
November 02, 2020
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), União Química Farmacêutica Nacional and the Government of the State of Paraná announce the pre-submission of preliminary documents to Brazil's National Health Surveillance Agency..
Dr Reddy’s partners with BIRAC for Sputnik V clinical trials in India expresspharma
October 30, 2020
The partnership will allow Dr Reddy’s to identify and use some of BIRAC’s clinical trial centres for the vaccine, which are funded under the National Biopharma Mission (NBM), implemented by Project Management Unit-NBM at BIRAC.
Russian application of Sputnik V vaccine for WHO vaccine prequalification among the first applications submitted worldpharmanews
October 29, 2020
The Russian Direct Investment Fund, (RDIF, Russia's sovereign wealth fund), has submitted applications to the World Health Organization (WHO) for accelerated registration (Emergency Use Listing, EUL) and prequalification of the world's first registered...
Dr Reddy’s, RDIF get DCGI nod for Phase II/III clinical trials of COVID-19 vaccine Sputnik V in India expresspharma
October 19, 2020
This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study.
RDIF and Trinity Pharma to supply 25 mn doses of Sputnik V vaccine to Nepal expresspharma
October 09, 2020
The agreement will enable 90 per cent of the population of Nepal to get access to Sputnik V vaccine.
RDIF and Dr Reddy’s to partner for trials and supply of 100 mn Sputnik V vaccine doses to India expresspharma
September 17, 2020
Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.

Previous page 1 2 Next page